Search

Your search keyword '"Guner, Rahmet"' showing total 196 results
Start Over Author "Guner, Rahmet" Publication Year Range Last 10 years
196 results on '"Guner, Rahmet"'

1. Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID–IRI study

Author

Erdem, Hakan, Kocoglu, Esra, Ankarali, Handan, El-Sokkary, Rehab, Hakamifard, Atousa, Karaali, Ridvan, Kulzhanova, Sholpan, El-Kholy, Amani, Tehrani, Hamed Azhdari, Khedr, Reham, Kaya-Kalem, Ayşe, Pandak, Nenad, Cagla-Sonmezer, Meliha, Nizamuddin, Summiya, Berk-Cam, Hande, Guner, Rahmet, Elkholy, Jehan Ali, Llopis, Ferran, Marino, Andrea, Stebel, Roman, Szabo, Balint Gergely, Belitova, Maya, Fadel, Elias, Yetisyigit, Tarkan, Cag, Yasemin, Alkan, Sevil, Kayaaslan, Bircan, Oncu, Serkan, Ozdemir, Mehmet, Yilmaz, Mesut, Isik, Arzu Cennet, Başkol, Dilşah, Sincan, Gulden, Cascio, Antonio, Ozer-Balin, Safak, Korkmaz, Nesibe, Ripon, Rezaul Karim, Abbas, Salma, Dumitru, Irina Magdalena, Eser-Karlidag, Gulden, Lanzafame, Massimiliano, Rafey, Abdur, Raza, Aun, Sipahi, Oguz Resat, Darazam, Ilad Alavi, Elbahr, Umran, Erdem, Ilknur, Ergen, Pinar, Bilir, Cemil, Caskurlu, Hulya, Erdem, Aysegul, Makek, Mateja Jankovic, Altindis, Mustafa, Lakatos, Botond, Luca, Catalina Mihaela, Yilmaz, Esmeray Mutlu, Nsutebu, Emmanuel, Cakmak, Rumeysa, and Sirmatel, Fatma

Published
2023
Full Text
View/download PDF

3. COVID-19: vaccination vs. hospitalization

Author

Uzun, Oguz, Akpolat, Tekin, Varol, Ayhan, Turan, Sema, Bektas, Serife Gokbulut, Cetinkaya, Pelin Duru, Dursun, Mazlum, Bakan, Nurten, Ketencioglu, Burcu Baran, Bayrak, Murat, Baris, Serap Argun, Guner, Rahmet, Gunal, Ozgur, Nural, Serkan, Deniz, Pelin Pinar, Toprak, Oya Baydar, Ozkan, Gulcihan, Gumus, Ayça, Kerget, Ferhan, Ercelik, Merve, Ataoglu, Ozlem, Yuksel, Aycan, Ates, Gungor, Kutsoylu, Oya Eren, Kose, Neslihan, Kizilirmak, Deniz, Keskin, Serdar, Gultekin, Okkes, Coskun, Nilüfer, Yilmaz, Emine Serap, Uslu, Selen, Basyigit, İlknur, Ergan, Begüm, Deveci, Figen, Yakar, Mehmet Nuri, Zuhur, Cigdem, Sagcan, Gulseren, Yuce, Zeynep Ture, Kuluozturk, Mutlu, Sezgin, Mehmet Emin, Sezgin, Esma Nur Aktepe, Havlucu, Yavuz, Cuhadaroglu, Caglar, Kilinc, Oguz, Boyaci, Hasim, Altunay, Hayriye, Akti, Mehmet, Dursun, Zehra Bastepe, Kalem, Ayse Kaya, Isik, Sinem Akkaya, Akyildiz, Levent, Aykac, Nilüfer, Almaz, Mehmet Selim, Kokturk, Nurdan, and Itil, Oya

Published
2022
Full Text
View/download PDF

4. Blood Culture Negative Endocarditis; What Do Concurrent Cardiac Disorders Tell Us?

Author

Filiz, Mine, primary, Erdem, Hakan, additional, Ankarali, Handan, additional, Puca, Edmond, additional, Ruch, Yvon, additional, Santos, Lurdes, additional, Ghanem-Zoubi, Nesrin, additional, Argemi, Xavier, additional, Hansmann, Yves, additional, Guner, Rahmet, additional, Tonziello, Gilda, additional, Mazzucotelli, Jean-Philippe, additional, Como, Najada, additional, Kose, Sukran, additional, Batirel, Ayse, additional, Inan, Asuman, additional, Tulek, Necla, additional, Pekok, Abdullah Umut, additional, Khan, Ejaz Ahmed, additional, Iyisoy, Atilla, additional, Meric-Koc, Meliha, additional, Kaya-Kalem, Ayse, additional, Martins, Pedro Palma, additional, Hasanoglu, Imran, additional, Silva-Pinto, André, additional, Oztoprak, Nefise, additional, Duro, Raquel, additional, Almajid, Fahad, additional, Dogan, Mustafa, additional, Dauby, Nicolas, additional, Gunst, Jesper Damsgaard, additional, Tekin, Recep, additional, Konopnicki, Deborah, additional, Petrosillo, Nicola, additional, Bozkurt, Ilkay, additional, Ramahi, Jamal Wadi Al, additional, Popescu, Corneliu, additional, Balkan, Ilker Inanc, additional, Ozer-Balin, Safak, additional, Zupanc, Tatjana Lejko, additional, Cascio, Antonio, additional, Dumitru, Irina Magdalena, additional, Erdem, Aysegul, additional, Ersoz, Gulden, additional, Tasbakan, Meltem, additional, Ajamieh, Oday Abu, additional, Sirmatel, Fatma, additional, Florescu, Simin, additional, Gulsun, Serda, additional, Ozkaya, Hacer Deniz, additional, Sari, Sema, additional, Tosun, Selma, additional, Avci, Meltem, additional, Cag, Yasemin, additional, Celebi, Guven, additional, Sagmak-Tartar, Ayse, additional, Karakus, Sumeyra, additional, Sener, Alper, additional, Dedej, Arjeta, additional, Oncu, Serkan, additional, Vecchio, Rosa Fontana Del, additional, Ozturk-Engin, Derya, additional, and Agalar, Canan, additional

Published
2024
Full Text
View/download PDF

5. Multicentre, randomised, double-blind, placebo-controlled, proof of concept study of LSALT peptide as prevention of acute respiratory distress syndrome and acute kidney injury in patients infected with SARS-CoV-2 (COVID-19)

Author

Somayaji, Ranjani, primary, Luke, David R, additional, Lau, Arthur, additional, Guner, Rahmet, additional, Tabak, Ŏ Fehmi, additional, Hepokoski, Mark, additional, Gardetto, Nancy, additional, Conrad, Steven A, additional, Kumar, Sunil D, additional, Ghosh, Kalyan, additional, Robbins, Stephen M, additional, Senger, Donna L, additional, Sun, Daisy, additional, Lim, Rachel K S, additional, Liu, Jonathan, additional, Eser, Fatma, additional, Karaali, Ridvan, additional, Tremblay, Alain, additional, and Muruve, Daniel, additional

Published
2024
Full Text
View/download PDF

9. Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study

Author

Sirmatel, Fatma, Cascio, Antonio, Lakatos, Botond, Oncu, Serkan, Willke, Ayse, Puca, Edmond, Koc, Meliha Meric, Korkmaz, Pinar, Karabay, Oguz, Guner, Rahmet, Caylak, Selmin Dirgen, Keceli, Sema, Cesur, Salih, Menekse, Sirin, Ergen, Pinar, Tasbakan, Mehmet Sezai, Erdem, Ayşegül, Cag, Yakup, Akcay, Emine, Fasciana, Teresa, Giammanco, Anna, Girgin, Rabia Burçin, Agalar, Canan, Vahaboglu, Haluk, Cag, Yasemin, Erdem, Hakan, Gunduz, Mehmet, Komur, Suheyla, Ankarali, Handan, Ural, Serap, Tasbakan, Meltem, Tattevin, Pierre, Tombak, Anil, Ozturk-Engin, Derya, Tartar, Ayse Sagmak, Batirel, Ayse, Tekin, Recep, Duygu, Fazilet, Caskurlu, Hulya, Kurtaran, Behice, Durdu, Bulent, Haciseyitoglu, Demet, and Rello, Jordi

Published
2022
Full Text
View/download PDF

11. Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir

Author

Guner, Rahmet, Hasanoglu, Imran, Kayaaslan, Bircan, Aypak, Adalet, Akinci, Esragul, Bodur, Hurrem, Eser, Fatma, Kaya Kalem, Ayse, Kucuksahin, Orhan, Ates, Ihsan, Bastug, Aliye, Tezer Tekce, Yasemin, Bilgic, Zeynep, Gursoy, Fahriye Melis, Akca, Hatice Nisa, Izdes, Seval, Erdem, Deniz, Asfuroglu, Emra, Hezer, Habibe, Kilic, Hatice, Cıvak, Musa, Aydogan, Sibel, and Buzgan, Turan

Published
2021
Full Text
View/download PDF

13. Development and validation of nomogram to predict severe illness requiring intensive care follow up in hospitalized COVID-19 cases

Author

Guner, Rahmet, Kayaaslan, Bircan, Hasanoglu, Imran, Aypak, Adalet, Bodur, Hurrem, Ates, Ihsan, Akinci, Esragul, Erdem, Deniz, Eser, Fatma, Izdes, Seval, Kalem, Ayse Kaya, Bastug, Aliye, Karalezli, Aysegul, Surel, Aziz Ahmet, Ayhan, Muge, Karaahmetoglu, Selma, Turan, Isıl Ozkocak, Arguder, Emine, Ozdemir, Burcu, Mutlu, Mehmet Nevzat, Bilir, Yesim Aybar, Sarıcaoglu, Elif Mukime, Gokcinar, Derya, Gunay, Sibel, Dinc, Bedia, Gemcioglu, Emin, Bilmez, Ruveyda, Aydos, Omer, Asilturk, Dilek, Inan, Osman, and Buzgan, Turan

Published
2021
Full Text
View/download PDF

15. Portraying infective endocarditis: results of multinational ID-IRI study

Author

Erdem, Hakan, Puca, Edmond, Ruch, Yvon, Santos, Lurdes, Ghanem-Zoubi, Nesrin, Argemi, Xavier, Hansmann, Yves, Guner, Rahmet, Tonziello, Gilda, Mazzucotelli, Jean-Philippe, Como, Najada, Kose, Sukran, Batirel, Ayse, Inan, Asuman, Tulek, Necla, Pekok, Abdullah Umut, Khan, Ejaz Ahmed, Iyisoy, Atilla, Meric-Koc, Meliha, Kaya-Kalem, Ayse, Martins, Pedro Palma, Hasanoglu, Imran, Silva-Pinto, André, Oztoprak, Nefise, Duro, Raquel, Almajid, Fahad, Dogan, Mustafa, Dauby, Nicolas, Gunst, Jesper Damsgaard, Tekin, Recep, Konopnicki, Deborah, Petrosillo, Nicola, Bozkurt, Ilkay, Wadi, Jamal, Popescu, Corneliu, Balkan, Ilker Inanc, Ozer-Balin, Safak, Zupanc, Tatjana Lejko, Cascio, Antonio, Dumitru, Irina Magdalena, Erdem, Aysegul, Ersoz, Gulden, Tasbakan, Meltem, Ajamieh, Oday Abu, Sirmatel, Fatma, Florescu, Simin, Gulsun, Serda, Ozkaya, Hacer Deniz, Sari, Sema, Tosun, Selma, Avci, Meltem, Cag, Yasemin, Celebi, Guven, Sagmak-Tartar, Ayse, Karakus, Sumeyra, Sener, Alper, Dedej, Arjeta, Oncu, Serkan, Del Vecchio, Rosa Fontana, Ozturk-Engin, Derya, and Agalar, Canan

Published
2019
Full Text
View/download PDF

16. Evaluation of bone mineral density in tenofovir disoproxil fumarate-treated patients with chronic hepatitis B.

Author

Ozdemir, Burcu, Altunsoy, Adalet, Hasanoglu, Imran, Akinci, Esragul, and Guner, Rahmet

Subjects
BONE density, TENOFOVIR, CHRONIC hepatitis B, OSTEOPOROSIS, PHOSPHORUS
Abstract

Aim: Evaluate the impact of Tenofovir Disoproxil Fumarate (TDF) treatment on bone mineral density (BMD) for patients with chronic hepatitis B (CHB) with Dual X-ray absorptiometry (DEXA) and the Fracture Risk Assessment Tool (FRAX) score. Materials and Methods: A total of 38 CHB patients treated with TDF were included in this retrospective study. To estimate BMD, DEXA, demographic details, and laboratory values were examined in patients. The BMD measurements were compared after dividing the patients into 3 groups as normal BMD, osteopenic, and osteoporotic. FRAX scores (before and after DEXA) were calculated. Results: Twenty-one of the 38 (55.3%) cases of CHB infection were male, the median age was 51 (min-max: 29-71) years, and seven patients (18.4%) were over 60 years of age. The median TDF duration was median 6 (min-max: 3-13) years. Osteopenia, defined by DEXA results, was found in 17 patients (44.7%) at the lumbar spine site, 11 (28.9%) at the femoral neck, and 10 (26.3%) at the total hip. Osteoporosis was detected in six patients (15.8%) at the lumbar spine site. Pre-DEXA FRAX score and post-DEXA FRAX score were calculated. Only one patient (1/33, 3%) had a score over the intervention threshold, by post-DEXA FRAX score. None of the patients classified as low risk based on the pre-DEXA FRAX score had a post-DEXA FRAX score above the intervention threshold. When the TDF duration, serum phosphorus level, vitamin D levels, and ALP levels were compared, no significant differences were found between the groups. Conclusion: There are concerns about the negative effects of TDF used in CHB infection on BMD. However, BMD loss may not increase as the duration of TDF use increases. FRAX score is useful in identifying to risk of osteoporotic fracture. FRAX score can also eliminate the need for DEXA in most CHB cases. The FRAX score should be used in clinical practice to determine cases at risk. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

18. A multinational Delphi consensus to end the COVID-19 public health threat

Author

Lazarus, Jeffrey V., Romero, Diana, Kopka, Christopher J., Karim, Salim Abdool, Abu-Raddad, Laith J., Almeida, Gisele, Baptista-Leite, Ricardo, Barocas, Joshua A., Barreto, Mauricio L., Bar-Yam, Yaneer, Bassat, Quique, Batista, Carolina, Bazilian, Morgan, Chiou, Shu-Ti, del Rio, Carlos, Dore, Gregory J., Gao, George F., Gostin, Lawrence O., Hellard, Margaret, Jimenez, Jose L., Kang, Gagandeep, Lee, Nancy, Matičič, Mojca, McKee, Martin, Nsanzimana, Sabin, Oliu-Barton, Miquel, Pradelski, Bary, Pyzik, Oksana, Rabin, Kenneth, Raina, Sunil, Rashid, Sabina Faiz, Rathe, Magdalena, Saenz, Rocio, Singh, Sudhvir, Trock-Hempler, Malene, Villapol, Sonia, Yap, Peiling, Binagwaho, Agnes, Kamarulzaman, Adeeba, El-Mohandes, Ayman, Barreto, Mauricio, Abdulla, Salim, Addleman, Sarah, Aghayeva, Gulnara, Agius, Raymond, Ahmed, Mohammed, Ramy, Mohamed Ahmed, Aide, Pedro, Aleman, Soo, Alfred, Jean-Patrick, Ali, Shamim, Aliaga, Jorge, Aloudat, Tammam, Alqahtani, Saleh A., Al-Salman, Jameela, Amuasi, John H., Agrawal, Anurag, Anwar, Wagida, Araujo-Jorge, Tania, Artaza, Osvaldo, Asadi, Leyla, Awuku, Yaw, Baker, Michael, Barberia, Lorena, Bascolo, Ernesto, Belcher, Paul, Bell, Lizett, Benzaken, Adele, Bergholtz, Emil, Bhadelia, Nahid, Bhan, Anant, Bilodeau, Stephane, Bitrán, Ricardo, Bluyssen, Philomena, Bosman, Arnold, Bozza, Fernando A., Brinkmann, Melanie M., Brown, Andrew, Mellado, Bruce, Bukusi, Elizabeth, Bullen, Chris, Buonanno, Giorgio, Burgess, Rochelle, Butler, Matthew, Byakika-Kibwika, Pauline, Cabieses, Baltica, Carlsson, Gunilla, Cascini, Fidelia, Chabala, Chishala, Chakroun, Mohamed, Cheng, null, Chetty, Agnes, Chumachenko, Dmytro, Consalves, Gregg, Conway Morris, Andrew, Cordie, Ahmed, Corrah, Tumani, Crabtree-Ramírez, Brenda, Dashdorj, Naranjargal, Davidovitch, Nadav, de Souza, Luis Eugenio, Dhariwal, Akshay Chand, Druică, Elena, Ergonul, Onder, Erondu, Ngozi A., Essar, Mohammad Yasir, Ewing, Andrew, Fanjul, Gonzalo, Feierstein, Daniel, Feigl-Ding, Eric, Figueroa, Ramon, Figueroa, John Peter, Fisher, Dale, Flores, Walter, Forero-Peña, David A., Frumkin, Howard, Gamkrelidze, Amiran, Gandhi, Monica, Garcia, Patricia, Garcia-Basteiro, Alberto L., García-Sastre, Adolfo, Garg, Suneela, Gbeasor-Komlanvi, null, Gershenson, Carlos, Gilada, Ishwar, Giovanella, Ligia, González, Marino, Green, Manfred S., Greenhalgh, Trisha, Griffin, Paul, Griffin, Stephen, Grinsztejn, Beatriz, Anand, Tanu, Guerra, Germán, Guinto, Renzo, Gujski, Mariusz, Guner, Rahmet, Hamdy, Adam, Hâncean, Marian-Gabriel, Haniffa, Abusayeed, Hartigan-Go, Kenneth Y., Hassan, Hoda K., Hay, Simon I., Heino, Matti T. J., Hel, Zdenek, Hotez, Peter, Hu, Jia, Hukić, Mirsada, IJsselmuiden, Carel, Iroko, Davidson, Iskarous, Maged, Izugbara, Chimaraoke, Jacobs, Choolwe, Jadad, Alejandro R., Jehan, Fyezah, Jordan, Ayana, Jroundi, Imane, Kain, Kevin, Kamberi, Fatjona, Karamov, Eduard, Karan, Abraar, Katz, Rebecca, Katzourakis, Aris, Kazembe, Abigail, Khamis, Faryal, Khamzayev, Komiljon, Khanyola, Judy, Khunti, Kamlesh, Kiguli-Malwadde, Elsie, Kim, Woo Joo, Kirenga, Bruce J., Klimovský, Daniel, Kmush, Brittany L., Knaul, Felicia, Kogevinas, Manolis, Kristensen, Frederik, Kumar, Dinesh, Kumar, Raman, Kvalsvig, Amanda, Lacerda, Marcus V., Lal, Arush, Lawton, Tom, Lemery, Jay, Leonardi, Anthony J., Li, Yuguo, Löttvall, Jan, Lounis, Mohamed, Maceira, Daniel, MacIntyre, C. Raina, Madani, Azzeddine, Magiorkinis, Gkikas, Malekzadeh, Reza, Choisy, Marc, Marcelin, Jasmine R., Marks, Guy B., Marr, Linsey, Marrazzo, Jeanne, Martina, Antonieta, Martín-Moreno, José M., Mateos, Carlos, Mayxay, Mayfong, Mazarati, Jean Bapiste, Mboup, Souleymane, McDonald, Jennifer, McMillan, Faye, Mechili, Enkeleint, Medici, Andre, Davis, Sarah L. M., Meier, Petra, Memish, Ziad A., Menon, Jaideep, Menon, Purnima, Mesiano-Crookston, Jonathan, Michie, Susan, Mikolasevic, Ivana, Milicevic, Ognjen, Mishra, Asit Kumar, Mohamed, Rahma, Mokdad, Ali H., Monroy-Valle, Michele, Morawska, Lidia, Moschos, Sterghios A., Motawea, Karam, Mousavi, Sayed Hamid, Mumtaz, Ghina, Munene, Peter K., Muñoz Almagro, Carmen, Muriuki, Janet, Muyingo, Sylvia, Naniche, Denise, Naylor, C. David, Ndembi, Nicaise, Nemec, Juraj, Nesteruk, Igor, Ngaruiya, Christine, Nguyen, Hung, Nikolova, Dafina, Nitzan, Dorit, Norheim, Ole, Noushad, Mohammed, Ntoumi, Francine, Nyborg, Gunhild Alvik, Ochodo, Eleanor, Odabasi, Zekaver, Okwen, Mbah Patrick, Olivia, Keiser, Ong, David S. Y., Opara, Ijeoma, Orozco, Miguel, Oshitani, Hitoshi, Pagel, Christina, Pai, Madhukar, Pálsdóttir, Björg, Papatheodoridis, Georgios, Paraskevis, Dimitrios, Leigh, Jeanna Parsons, Pécoul, Bernard, Peichl, Andreas, Perez-Then, Eddy, Duc, Phuc Pham, Philippe, Cécile, Pineda Rojas, Andrea, Pladsen, Courtney, Pozniak, Anton, Quiroga, Rodrigo, Qureshi, Huma, Rampal, Sanjay, Ranney, Megan, Rathe, Laura, Ratzan, Scott, Raventos, Henriette, Rees, Helen, Reis, Renata, Ricciardi, Walter, Rizk, Nesrine, Robalo, Magda, Robertson, Eleanor, Robinson, Leanne, Rokx, Casper, Ros, Tamsin, Røttingen, John-Arne, Rubin, Meir, Ruxrungtam, Kiat, Sadirova, Shakhlo, Saha, Senjuti, Salgado, Nelly, Sanchez, Lizet, Sangaramoorthy, Thurka, Santamaria-Ulloa, Carolina, Santos, Renata, Sawaf, Bisher, Schneider, Matthias F., Schooley, Robert T., Sener, Alper, Sepulveda, Jaime, Shah, Jaffer, Shibani, Mosa, Shoib, Sheikh, Sikazwe, Izukanji, Šimaitis, Aistis, Gill, Amandeep Singh, Skhvitaridze, Natia, Sokolović, Milka, Solomon, Roma, Solórzano, Xavier, Springer, Sandra A., Šrol, Jakub, Staines, Anthony, Stelfox, Henry T., Strathdee, Steffanie, Sulaiman, Lokman Hakim, Sutton, Brett, Svanæs, Dag, Swed, Sarya, Sypsa, Vana, Sørensen, Kristine, Tajudeen, Raji, Tan, Amy, Tang, Julian, Tanner, Marcel, Sethi, Tavpritesh, Temmerman, Marleen, Than, Kyu Kyu, Tinto, Halidou, Tomètissi, Sênoudé Pacôme, Torres, Irene, Tshering, null, Tsiodras, Sotirios, Tsofa, Benjamin, Vahlne, Anders, Vargas, Juan Rafael, Bernal, Ivan Dario Velez, Ventura, Deisy, Vilasanjuan, Rafael, Vipond, Joe, Wamala-Andersson, Sarah, Wargocki, Pawel, West, Robert, Weyand, Angela, White, Trenton M., Wolff, Guntram, Yao, Maosheng, Yates, Christian A., Yeboah, Georgina, Yee-Sin, Leo, Yi, Siyan, Teo, Yik-Ying, Yong, Poovorawan, Zamora-Mesía, Victor, Øvrehus, Anne, 0000-0001-9618-2299, 0000-0002-4832-9564, 0000-0002-4986-2133, 0000-0003-0790-0506, 0000-0003-0875-7596, 0000-0002-6994-1891, 0000-0002-3869-615X, 0000-0001-5286-4044, 0000-0001-6203-1847, 0000-0002-0121-9683, 0000-0003-1793-6350, 0000-0003-2418-0037, 0000-0002-5095-748X, 0000-0003-4492-3256, 0000-0002-5964-8210, 0000-0002-6779-3151, 0000-0002-8074-4450, Lazarus, Jeffrey V [0000-0001-9618-2299], Romero, Diana [0000-0002-4832-9564], Karim, Salim Abdool [0000-0002-4986-2133], Abu-Raddad, Laith J [0000-0003-0790-0506], Bassat, Quique [0000-0003-0875-7596], Chiou, Shu-Ti [0000-0002-6994-1891], Gao, George F [0000-0002-3869-615X], Gostin, Lawrence O [0000-0001-5286-4044], Jimenez, Jose L [0000-0001-6203-1847], McKee, Martin [0000-0002-0121-9683], Oliu-Barton, Miquel [0000-0003-1793-6350], Pradelski, Bary [0000-0003-2418-0037], Rathe, Magdalena [0000-0002-5095-748X], Trock-Hempler, Malene [0000-0003-4492-3256], Yap, Peiling [0000-0002-5964-8210], Binagwaho, Agnes [0000-0002-6779-3151], Kamarulzaman, Adeeba [0000-0002-8074-4450], Apollo - University of Cambridge Repository, Helsinki Collegium for Advanced Studies, Research Group of Nelli Hankonen, Doctoral Programme in Social Sciences, Academic Disciplines of the Faculty of Social Sciences, RS: CAPHRI - R2 - Creating Value-Based Health Care, International Health, Performance analysis and optimization of LARge Infrastructures and Systems (POLARIS), Inria Grenoble - Rhône-Alpes, Institut National de Recherche en Informatique et en Automatique (Inria)-Institut National de Recherche en Informatique et en Automatique (Inria)-Laboratoire d'Informatique de Grenoble (LIG), Université Pierre Mendès France - Grenoble 2 (UPMF)-Université Joseph Fourier - Grenoble 1 (UJF)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Institut National Polytechnique de Grenoble (INPG)-Centre National de la Recherche Scientifique (CNRS)-Université Pierre Mendès France - Grenoble 2 (UPMF)-Université Joseph Fourier - Grenoble 1 (UJF)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Institut National Polytechnique de Grenoble (INPG)-Centre National de la Recherche Scientifique (CNRS), Internal Medicine, Medical Microbiology & Infectious Diseases, Veritati - Repositório Institucional da Universidade Católica Portuguesa, and Lazarus J. V., Romero D., Kopka C. J., Karim S. A., Abu-Raddad L. J., Almeida G., Baptista-Leite R., Barocas J. A., Barreto M. L., Bar-Yam Y., et al.

Subjects
Pandemics/economics, BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences, COVID-19 Vaccines, Delphi Technique, General Science & Technology, International Cooperation, Temel Bilimler (SCI), ÇOK DİSİPLİNLİ BİLİMLER, Public Health/economics, [SHS]Humanities and Social Sciences, SDG 3 - Good Health and Well-being, RA0421 Public health. Hygiene. Preventive Medicine, Medicine and Health Sciences, Humans, prevention and control, human, Settore MED/42 - IGIENE GENERALE E APPLICATA, Health Education, Pandemics, Multidisipliner, Organizations, Multidisciplinary, MULTIDISCIPLINARY SCIENCES, COVID-19/economics, Temel Bilimler, pandemic, Communication, Health Policy, BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti, Doğa Bilimleri Genel, COVID-19, 3142 Public health care science, environmental and occupational health, Delphi study, NATURAL SCIENCES, GENERAL, N/A, Public Opinion, Government, Natural Sciences (SCI), Public Health, Natural Sciences
Abstract

Despite notable scientific and medical advances, broader political, socioeconomic and behavioural factors continue to undercut the response to the COVID-19 pandemic . Here we convened, as part of this Delphi study, a diverse, multidisciplinary panel of 386 academic, health, non-governmental organization, government and other experts in COVID-19 response from 112 countries and territories to recommend specific actions to end this persistent global threat to public health. The panel developed a set of 41 consensus statements and 57 recommendations to governments, health systems, industry and other key stakeholders across six domains: communication; health systems; vaccination; prevention; treatment and care; and inequities. In the wake of nearly three years of fragmented global and national responses, it is instructive to note that three of the highest-ranked recommendations call for the adoption of whole-of-society and whole-of-government approaches , while maintaining proven prevention measures using a vaccines-plus approach that employs a range of public health and financial support measures to complement vaccination. Other recommendations with at least 99% combined agreement advise governments and other stakeholders to improve communication, rebuild public trust and engage communities in the management of pandemic responses. The findings of the study, which have been further endorsed by 184 organizations globally, include points of unanimous agreement, as well as six recommendations with >5% disagreement, that provide health and social policy actions to address inadequacies in the pandemic response and help to bring this public health threat to an end.

Published
2022

19. Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients

Author

Kilic, Hatice, primary, Arguder, Emine, additional, Karalezli, Aysegul, additional, Unsal, Ebru, additional, Guner, Rahmet, additional, Kayaslan, Bircan, additional, Hasanoglu, İmran, additional, Ates, İhsan, additional, Civak, Musa, additional, Akpınar, Esmehan, additional, Parlak, Ebru, additional, Sadi, Filiz, additional, Kocaman, Yasin, additional, Günay, Sibel, additional, Metan, Esra, additional, Er, Mukremin, additional, Dalkıran, Aynil, additional, Hezer, Habibe, additional, Ergüden, Hülya, additional, Hancıoğlu, Zeynep, additional, Kalem, Ayşe, additional, Eser, Fatma, additional, Aypak, Adalet, additional, Akıncı, Esragül, additional, Karahmetoğlu, Selma, additional, Gemcioglu, Emin, additional, Kalkan, Emra, additional, İnan, Osman, additional, Yilmaz, Abdulrezzak, additional, Güler, Bagdagul, additional, Çopuroğlu, Esra, additional, Turan, İşil, additional, Gökmen, Derya, additional, Hayme, Serhat, additional, and Surel, Aziz Ahmet, additional

Published
2022
Full Text
View/download PDF

20. Development and validation of COVID ‐19 associated candidemia score ( CAC‐Score ) in ICU patients

Author

Kayaaslan, Bircan, primary, Eser, Fatma, additional, Asilturk, Dilek, additional, Oktay, Zeynep, additional, Hasanoglu, Imran, additional, Kalem, Ayşe Kaya, additional, Dönertaş, Gülen, additional, Kaplan, Betul, additional, Ozkocak Turan, Isıl, additional, Erdem, Deniz, additional, Bektas, Hesna, additional, and Guner, Rahmet, additional

Published
2022
Full Text
View/download PDF

21. Real life efficacy, renal and lipid profile data of tenofovir alafenamide in switched chronic hepatitis B patients

Author

Guner, Rahmet, primary, Yoruk, Gulsen, additional, Karabay, Oguz, additional, Yamazhan, Tansu, additional, Baykam, Nurcan, additional, Yildirim, Mustafa, additional, Ince, Nevin, additional, Yildiz, Ilknur Esen, additional, Dökmetaş, İlyas, additional, Koç, Melihe Meriç, additional, Koksal, Iftihar, additional, Köse, Sükran, additional, Ceken, Sabahat, additional, Inan, Dilara, additional, Bozkurt, I., additional, Turker, Kamuran, additional, Celebi, Güven, additional, Batirel, Ayse, additional, Unlu, Gulten, additional, Gunal, Ozgur, additional, Gorenek, Levent, additional, Sirmatel, Fatma, additional, Sener, Alper, additional, Parlak, Emine, additional, and Tabak, Fehmi, additional

Published
2022
Full Text
View/download PDF

22. Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study

Author

Cag, Yasemin, primary, Erdem, Hakan, additional, Gunduz, Mehmet, additional, Komur, Suheyla, additional, Ankarali, Handan, additional, Ural, Serap, additional, Tasbakan, Meltem, additional, Tattevin, Pierre, additional, Tombak, Anil, additional, Ozturk-Engin, Derya, additional, Tartar, Ayse Sagmak, additional, Batirel, Ayse, additional, Tekin, Recep, additional, Duygu, Fazilet, additional, Caskurlu, Hulya, additional, Kurtaran, Behice, additional, Durdu, Bulent, additional, Haciseyitoglu, Demet, additional, Rello, Jordi, additional, Sirmatel, Fatma, additional, Cascio, Antonio, additional, Lakatos, Botond, additional, Oncu, Serkan, additional, Willke, Ayse, additional, Puca, Edmond, additional, Koc, Meliha Meric, additional, Korkmaz, Pinar, additional, Karabay, Oguz, additional, Guner, Rahmet, additional, Caylak, Selmin Dirgen, additional, Keceli, Sema, additional, Cesur, Salih, additional, Menekse, Sirin, additional, Ergen, Pinar, additional, Tasbakan, Mehmet Sezai, additional, Erdem, Ayşegül, additional, Cag, Yakup, additional, Akcay, Emine, additional, Fasciana, Teresa, additional, Giammanco, Anna, additional, Girgin, Rabia Burçin, additional, Agalar, Canan, additional, and Vahaboglu, Haluk, additional

Published
2022
Full Text
View/download PDF

23. WED-418 A national multicenter study on initial antiviral treatment preferences on chronic hepatitis B: Entecavir versus Tenofovir disoproxil fumarate

Author

Yamazhan, Tansu, Zerdali, Esra, Onlen, Yusuf, Tosun, Selma, Günal, Özgür, Batirel, Ayse, Hasanoğlu, İmran, Turunç, Tuba, Balcı, Umay, Kaya, Sibel Yildiz, Karabay, Oğuz, Yildiz, Ilknur Esen, Altunal, Lütfiye Nilsun, Ozkaya, Deniz Cevahir, Kaya, Selçuk, İnci, Ayşe, Alkan, Sevil, Yildiz, Dilek, Bal, Tayibe, Aydemir, Esma Aslıhan, Eser, Nurullah, Uysal, Serhat, Tabak, Fehmi, and Guner, Rahmet

Published
2024
Full Text
View/download PDF

24. Development and validation of COVID‐19 associated candidemia score (CAC‐Score) in ICU patients.

Author

Kayaaslan, Bircan, Eser, Fatma, Asilturk, Dilek, Oktay, Zeynep, Hasanoglu, Imran, Kalem, Ayşe Kaya, Dönertaş, Gülen, Kaplan, Betul, Ozkocak Turan, Isıl, Erdem, Deniz, Bektas, Hesna, and Guner, Rahmet

Subjects
CANDIDEMIA, CENTRAL venous catheters, COVID-19, INTENSIVE care units, URBAN hospitals
Abstract

Background: The development of candidemia is a highly fatal condition in severe COVID‐19 infection. Objectives: This study aimed to develop a candidemia prediction score in COVID‐19 patient based on the patient's clinical characteristics, and healthcare‐related factors during intensive care units (ICU) follow‐up. Patients/Methods: Severe COVID‐19 patients hospitalised in ICU in Ankara City Hospital during the one‐year period (August 15, 2020, and August 15, 2021) were included. After univariate analysis, multivariate analysis was applied using variable selection approach to investigate the effects of variables together and to create a score model for candidemia. Statistically significant factors were included in the development process of candida prediction score. Results: Of 1305 COVID‐19 ICU patients, 139 had a candidemia episode. According to the final model, four variables, presence of central venous catheter (CVC) (OR 19.07, CI 8.12–44.8, p <.0001), multifocal colonisation (OR 2.28, CI 1.39–3.72, p 0.001), length of ICU stays ≥14 days (OR 3.62, CI 2.42–5.44, p <.0001) and corticosteroids (OR 0.51, CI 0.34–0.76, p 0.0011) were the only statistically significant independent risk factors for candidemia. Score model was demonstrated by a nomogram, and the risk for candidemia was calculated to be high in patients who scored ≥56 points by using the criteria [CVC = 51, multifocal colonisation = 14, prolonged hospitalisation = 23, no steroid use = 12 points]. The AUC of the score is 0.84 (CI 0.81–0.87). Conclusion: We developed and validated an easy‐to‐use clinical prediction score for candidemia in severe COVID‐19 infection. In COVID‐19 ICU patients, the risk of candidemia is high if one of the other risk factors is present together with CVC. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

25. Incidence and risk factors for COVID‐19 associated candidemia (CAC) in ICU patients

Author

Kayaaslan, Bircan, primary, Kaya Kalem, Ayşe, additional, Asilturk, Dilek, additional, Kaplan, Betul, additional, Dönertas, Gülen, additional, Hasanoglu, Imran, additional, Eser, Fatma, additional, Korkmazer, Ruveyda, additional, Oktay, Zeynep, additional, Ozkocak Turan, Isıl, additional, Erdem, Deniz, additional, Bektas, Hesna, additional, and Guner, Rahmet, additional

Published
2022
Full Text
View/download PDF

26. Real life efficacy, renal and lipid profile data of tenofovir alafenamide in switched chronic hepatitis B patients

Author

Tabak, Fehmi, Guner, Rahmet, Yoruk, Gulsen, Karabay, Oguz, Yamazhan, Tansu, Baykam, Nurcan, Yildirim, Mustafa, Ince, Nevin, YILDIZ, İLKNUR ESEN, Dokmetas, Ilyas, MERİÇ KOÇ, MELİHA, Koksal, Iftihar, Ceken, Sabahat, Inan, Dilara, Bozkurt, I., Turker, Kamuran, Celebi, Guven, Batirel, Ayse, Unlu, Gulten, Gunal, Ozgur, Gorenek, Levent, Sirmatel, Fatma, Sener, Alper, Parlak, Emine, and Kose, ŞÜKRAN

Subjects
Hepatology
Published
2022

28. Eliminating Viral Hepatitis in Turkey: Achievements and Challenges

Author

Akarca, Ulus Salih, Baykam, Nurcan, Guner, Rahmet, Gunsar, Fulya, Idilman, Ramazan, Kaymakoglu, Sabahattin, and Koksal, Iftihar

Subjects
HCV, HBV, COVID-19, C Virus, B-Virus Infection
Abstract

After the declaration Global Health Sector Strategy on Viral Hepatitis by the World Health Organization in 2016, the Turkish Government defined a national strategy covering 2018-2023 to reach goals by 2030. Following a participatory decision process and a series of workshops, the strategy was built on eight separate subheadings. Apart from the official Prevention and Control Program, two separate road maps for hepatitis B and C were developed to obtain targets accessible with the cooperation of the Viral Hepatitis Society and the Turkish Association for the Study of the Liver in 2018 and 2020, respectively. Up to 2023, achievements and the current situation of the National Viral Hepatitis Prevention and Control Program and the hepatitis B virus and hepatitis C virus road maps were assessed in detail on June 28th, 2022, by the subject matter experts in Turkey. Besides the officially reported achievement rate (42%) of the Program in 2021, participants mentioned undesirable effects of the coronavirus disease-2019 pandemic, unregulated migration, low levels of professional and public awareness, and barriers to access to anti-viral treatment. Recommendations focused on increasing the efficiency of screening and surveillance by integrating the viral carrier identity of individuals into the national health information system, simplifying the drug supplement and treatment initiation process and insisting on education to raise awareness.

Published
2022

29. Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial.

Author

Tanriover, Mine Durusu, Aydin, Ozlem Altuntas, Guner, Rahmet, Yildiz, Orhan, Celik, Ilhami, Doganay, Hamdi Levent, Kose, Sukran, Akhan, Sila, Akalin, Emin Halis, Sezer, Zafer, Ozdarendeli, Aykut, and Unal, Serhat

Subjects
CLINICAL trials, SARS-CoV-2, COVID-19 vaccines, COVID-19, IMMUNE response
Abstract

We present the interim results of the efficacy, immunogenicity, and safety of the two-dose schedules of TURKOVAC versus CoronaVac. This was a randomized, observer-blinded, non-inferiority trial (NCT04942405). Volunteers were 18–55 years old and randomized at a 1:1 ratio to receive either TURKOVAC or CoronaVac at Day 0 and Day 28, both of which are 3 μg/0.5 mL of inactivated severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) adsorbed to aluminum hydroxide. The primary efficacy outcome was the prevention of polymerase chain reaction (PCR)-confirmed symptomatic coronavirus disease 2019 (COVID-19) at least 14 days after the second dose in the modified per-protocol (mPP) group. Safety analyses were performed in the modified intention-to-treat (mITT) group. Between 22 June 2021 and 7 January 2022, 1290 participants were randomized. The mITT group consisted of 915 participants, and the mPP group consisted of 732 participants. During a median follow-up of 90 (IQR 86–90) days, the relative risk reduction with TURKOVAC compared to CoronaVac was 41.03% (95% CI 12.95–60.06) for preventing PCR-confirmed symptomatic COVID-19. The incidences of adverse events (AEs) overall were 58.8% in TURKOVAC and 49.7% in CoronaVac arms (p = 0.006), with no fatalities or grade four AEs. TURKOVAC was non-inferior to CoronaVac in terms of efficacy and demonstrated a good safety and tolerability profile. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

30. Response to the letter to the editor

Author

Guner, Rahmet, Hasanoglu, Imran, Kayaaslan, Bircan, Aypak, Adalet, Akinci, Esragul, Bodur, Hurrem, Eser, Fatma, Kaya Kalem, Ayse, Kucuksahin, Orhan, Ates, Ihsan, Bastug, Aliye, Tezer Tekce, Yasemin, Bilgic, Zeynep, Gursoy, Fahriye Melis, Akca, Hatice Nisa, Izdes, Seval, Erdem, Deniz, Asfuroglu, Emra, Hezer, Habibe, Kilic, Hatice, Civak, Musa, Aydogan, Sibel, and Buzgan, Turan

Published
2022
Full Text
View/download PDF

32. Surveillance of Hemodialysis Related Infections: A Prospective Multicenter Study

Author

Hasanoglu, İmran, primary, Guner, Rahmet, additional, Sahin, Suzan, additional, Karadag, Fatma Yilmaz, additional, Parmaksiz, Ergun, additional, Atalay, Haci Veli, additional, Ecder, Sabahat Alisir, additional, Gulen, Tugba Arslan, additional, Ucar, Zuhal Atan, additional, Karabay, Oguz, additional, Sipahi, Savas, additional, Kilic, Esra Kaya, additional, Duranay, Murat, additional, Yapar, Derya, additional, Dogan, Ibrahim, additional, Ersoz, Gulden, additional, Turkmen, Gulcan, additional, and Kiykim, Ahmet Alper, additional

Published
2022
Full Text
View/download PDF

42. Characteristics of candidemia in COVID‐19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non‐COVID‐19 patients

Author

Kayaaslan, Bircan, primary, Eser, Fatma, additional, Kaya Kalem, Ayşe, additional, Bilgic, Zeynep, additional, Asilturk, Dilek, additional, Hasanoglu, Imran, additional, Ayhan, Muge, additional, Tezer Tekce, Yasemin, additional, Erdem, Deniz, additional, Turan, Sema, additional, Mumcuoglu, Ipek, additional, and Guner, Rahmet, additional

Published
2021
Full Text
View/download PDF

43. Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B

Author

Koklu, S., Gulsen, M. T., Tuna, Y., Koklu, H., Yuksel, O., Demir, M., Guner, R., Dogan, Z., Kucukazman, M., Poyrazoglu, O. K., Biyik, M., Ozturk, N. A., Aydogan, T., Coban, S., Kocaman, O., Sapmaz, F., Gokturk, S. H., Karaca, C., Demirezer, A., Tanoglu, A., Yildirim, B., Altinbas, A., Atak, B. M., Cosar, A. M., Alkan, E., Koklu, Seyfettin, Gulsen, Murat Taner, Tuna, Yasar, Koklu, Hayretdin, Yuksel, Osman, Demir, Mehmet, Guner, Rahmet, Dogan, Zeynal, Kucukazman, Metin, Poyrazoglu, Orhan Kursat, Biyik, Murat, Ozturk, Nevin A., Aydogan, Timucin, Coban, Sahin, Kocaman, Orhan, Sapmaz, Ferda, Gokturk, Savas H., Karaca, Cetin, Demirezer, Aylin, Tanoglu, Alpaslan, Yildirim, Beytullah, Altinbas, Akif, Atak, Burcu M., Cosar, Arif M., Alkan, Erhan, Tufan, Zeliha K., Kekilli, Murat, Ataseven, Huseyin, Purnak, Tugrul, Basar, Omer, Koklu, Nimet, Ozturk, Omer, Bakkaloglu, Kagan, Besisik, Fatih, Kockar, Cem, Arslan, Serab, and Unverdi, Selman

Published
2015
Full Text
View/download PDF

44. Additional file 1 of Development and validation of nomogram to predict severe illness requiring intensive care follow up in hospitalized COVID-19 cases

Author

Guner, Rahmet, Kayaaslan, Bircan, Hasanoglu, Imran, Aypak, Adalet, Bodur, Hurrem, Ates, Ihsan, Akinci, Esragul, Erdem, Deniz, Eser, Fatma, Izdes, Seval, Kalem, Ayse Kaya, Bastug, Aliye, Karalezli, Aysegul, Surel, Aziz Ahmet, Ayhan, Muge, Karaahmetoglu, Selma, Turan, Isıl Ozkocak, Arguder, Emine, Ozdemir, Burcu, Mutlu, Mehmet Nevzat, Bilir, Yesim Aybar, Sarıcaoglu, Elif Mukime, Gokcinar, Derya, Gunay, Sibel, Dinc, Bedia, Gemcioglu, Emin, Bilmez, Ruveyda, Aydos, Omer, Asilturk, Dilek, Inan, Osman, and Buzgan, Turan

Abstract

Additional file 1: Table S1. Score assignment for each variable included in nomogram and calculation the risk for ICU admission based on total point. Table S2. Calibration indexes of the nomogram model.

Published
2021
Full Text
View/download PDF

45. The Evaluation of Relationship between Monocyte/High-Density Lipoprotein Ratio (MHR) and COVID-19.

Author

Coskun, Belgin, Ayhan, Muge, Saricaoglu, Elif Mukime, Guner, Rahmet, Akinci, Esragül, Buzgan, Turan, Kayaaslan, Bircan, Altunsoy, Adalet, Tezer Tekce, Ayse Yasemin, Hasanoglu, Imran, Kalem, Ayse Kaya, Eser, Fatma, Bilir, Yesim Aybar, and Ozdemir, Burcu

Subjects
BIOMARKERS, LENGTH of stay in hospitals, HDL cholesterol, GLOMERULAR filtration rate, TROPONIN, C-reactive protein, ALBUMINS, TRIGLYCERIDES, PROTHROMBIN time, COVID-19, HEMOGLOBINS, INFLAMMATION, RETROSPECTIVE studies, ACQUISITION of data, FISHER exact test, CALCITONIN, SEVERITY of illness index, CYTOKINE release syndrome, HYPERLIPIDEMIA, ARTIFICIAL respiration, NEUTROPHIL lymphocyte ratio, MEDICAL records, DESCRIPTIVE statistics, CHI-squared test, FIBRINOGEN, HIGH density lipoproteins, DATA analysis software, BLOOD cell count, INTERNATIONAL normalized ratio, MONOCYTES, COMORBIDITY, ALANINE aminotransferase, ASPARTATE aminotransferase, CREATININE, CHOLESTEROL
Abstract

Copyright of Konuralp Medical Journal / Konuralp Tip Dergisi is the property of Duzce University Medical School and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2022
Full Text
View/download PDF

47. A notable key for estimating the severity of COVID-19: 25-hydroxyvitamin D status

Author

Ergin Tuncay, Merve, primary, Gemcioglu, Emin, additional, Kayaaslan, Bircan, additional, Ates, Ihsan, additional, Guner, Rahmet, additional, Eser, Fatma, additional, Hasanoglu, Imran, additional, Kaya Kalem, Ayse, additional, Aypak, Adalet, additional, Agac, Zubeyr Said, additional, Gokbulut Bektas, Serife, additional, Mungan, Ibrahim, additional, Akdag, Ahmet Gokhan, additional, Izdes, Seval, additional, Neselioglu, Salim, additional, and Erel, Ozcan, additional

Published
2021
Full Text
View/download PDF

48. Evaluation of 17 patients with COVID‐19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA, and Brescia‐COVID respiratory severity scale (BCRSS) scoring systems

Author

Erden, Abdulsamet, primary, Ozdemir, Bahar, additional, Karakas, Ozlem, additional, Mutlu, Nevzat Mehmet, additional, Izdes, Seval, additional, Kalem, Ayse Kaya, additional, Bilir, Yeşim Aybar, additional, Aypak, Adalet, additional, Akinci, Esragul, additional, Guner, Rahmet, additional, and Kucuksahin, Orhan, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results